Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Assay and Drug Development Technologies|January 10, 2008
HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virusPaul A Johnston, Jennifer Phillips, Tong Ying Shun, et al.Journal of Medicinal Chemistry|April 17, 2014
Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependenceRaveendra-Panickar Dhanya, Douglas J Sheffler, Russell Dahl, et al.Biorxiv : the Preprint Server for Biology|May 5, 2025
Failed Metabolic Adaptation to Stress Underlies Pathogenesis in a Heterozygous Genetic DisorderRobert Harmon, Erin McCarthy, Annette Krol, et al.Journal of Medicinal Chemistry|February 24, 2011
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cellsStephanie M Stanford, Divya Krishnamurthy, Matthew D Falk, et al.Nature Chemical Biology|March 20, 2012
LYP inhibits T-cell activation when dissociated from CSKTorkel Vang, Wallace H Liu, Laurence Delacroix, et al.Journal of Medicinal Chemistry|May 5, 2011
Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation IaRussell Dahl, Yalda Bravo, Vandana Sharma, et al.Molecular Cancer Therapeutics|April 18, 2009
Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteinsJun Wei, Shinichi Kitada, Michele F Rega, et al.Bioorganic & Medicinal Chemistry Letters|October 7, 2008
'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.European Journal of Pharmacology|February 6, 2010
KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinaseAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.Bioorganic & Medicinal Chemistry Letters|March 8, 2008
The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.Pageof 7